河南省中医院
纸质出版:2016
移动端阅览
[1]任冬冬,贾合磊,郭燕可,胡仕祥,崔应麟.活血通脉汤联合西药对冠状动脉支架植入术后再狭窄患者的影响[J].中医杂志,2016,57(04):311-315.
REN Dongdong, JIA Helei, GUO Yanke, et al. Effects of Huoxue Tongmai Tang( 活血通脉汤) Combined with Western Medicine to Restenosis in Patients after Coronary Artery Stenting[J]. Journal of Traditional Chinese Medicine2016, 57(4): 311-315.
[1]任冬冬,贾合磊,郭燕可,胡仕祥,崔应麟.活血通脉汤联合西药对冠状动脉支架植入术后再狭窄患者的影响[J].中医杂志,2016,57(04):311-315. DOI: 10.13288/j.11-2166/r.2016.04.011.
REN Dongdong, JIA Helei, GUO Yanke, et al. Effects of Huoxue Tongmai Tang( 活血通脉汤) Combined with Western Medicine to Restenosis in Patients after Coronary Artery Stenting[J]. Journal of Traditional Chinese Medicine2016, 57(4): 311-315. DOI: 10.13288/j.11-2166/r.2016.04.011.
目的观察活血通脉汤联合西医常规治疗防治冠状动脉支架植入术后再狭窄的疗效及可能机制。方法将成功行冠状动脉支架置入术的急性冠脉综合征患者60例随机分为治疗组和对照组各30例。对照组给予西医常规治疗
治疗组在对照组的基础上加服活血通脉汤
每日1剂
两组均治疗6个月。于术前、术后及服药6个月后观察两组血浆患者氧化低密度脂蛋白(ox-LDL)、高敏C-反应蛋白(hs-CRP)、血脂[包括总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)]、中医证候积分及心绞痛症状积分的变化
并比较术后支架再狭窄支数。结果两组术后hs-CRP、ox-LDL、TC、TG及LDL-C、中医证候积分和心绞痛症状积分与术前比较明显减低
HDL-C明显升高(P<0.05);治疗组服药6个月后hs-CRP低于术后
ox-LDL、心绞痛症状积分和中医证候积分高于术后
而对照组hsCRP、TC、TG、LDL-C、心绞痛症状积分和中医证候积分均高于术后
HDL-C低于术后(均P<0.05);治疗6个月后治疗组hs-CRP、ox-LDL、TC、TG和LDL-C低于术前
HDL-C高于术前(均P<0.05)
心绞痛症状积分和中医证候积分两组均低于术前(P<0.05);治疗组服药6个月后hs-CRP、ox-LDL、TC、TG、LDL-C、心绞痛症状积分和中医证候积分与对照组同时间比较明显减低
而HDL-C高于对照组(P<0.05)。治疗组患者术后普通支架(1支)、药物洗脱支架(0支)及总支架再狭窄数(1支)与对照组比较(分别为5支、2支、7支)均明显降低(P<0.05)。结论活血通脉汤联合西医常规治疗能够减少冠状动脉支架植入术后再狭窄情况
明显缓解术后患者的临床症状
其作用机理可能与改善血脂及降低血浆ox-LDL、hs-CRP水平有关。
Objective To observe the curative effects and possible mechanism of Huoxue Tongmai Tang combined with conventional western medicine therapy to prevent and control restenosis of patients after coronary artery stenting. Methods Sixty patients with acute coronary syndrome after successful coronary artery stenting were randomly divided into the treatment group and the control group
with 30 cases in each group. Both groups were given conventional therapy of western medicine
and the treatment group was also added with Huoxue Tongmai Tang
1 dose daily. Both groups were treated for six months. Before operation
just after operation and after medication for 6months that been given Chinese medicine
the changes in plasma levels of oxidized low-density lipoprotein( ox-LDL)
high-sensitivity C-reactive protein( hs-CRP) and blood lipids( including total cholesterol( TC)
triglyceride( TG)
low-density lipoprotein cholesterol( LDL-C)
and high-density lipoprotein cholesterol( HDL-C) ]
Chinese medical syndrome integral
and angina symptom integral of patients in two groups were observed
and the numbers of restenosis after operation were compared. Results Levels of hs-CRP
ox-LDL
TC
TG
and LDL-C
Chinese medical syndrome integral
and angina symptom integral reduced obviously
but HDL-C increased obviously in the two groups just after operation comparing with before the operation( P < 0. 05). After taking Chinese medicine for 6 months
level of hs-CRP was lower
but level of ox-LDL
angina symptom integral
and Chinese medical syndrome integral were higher in the treatment group than that before operation. Levels of hs-CRP
TC
TG
and LDL-C
angina symptom integral
and Chinese medical syndrome integral were higher
but HDL-C was lower in the control group than those just after operation( all P < 0. 05). After taking Chinese medicine for 6 months
levels of hs-CRP
ox-LDL
TC
TG
and LDL-C were lower
but HDL-C was higher in the treatment group than those just after operation( P <0. 05)
and angina symptom integral and Chinese medical syndrome integral in the two groups were lower than those before operation( P < 0. 05). After taking Chinese medicine for 6 months
levels of hs-CRP
ox-LDL
TC
TG
and LDL-C
angina symptom integral
and Chinese medical syndrome integral in the treatment group were lower
but HDL-C was higher than those in the control group at the same timepoint( P < 0. 05). After operation there were one ordinary stent
non drug-eluting stent
and one restenosis in the treatment group
which were much lower than 5 ordinary stents
2 drug-eluting stents
and 7 restenosis in the control group( P < 0. 05). Conclusion Huoxue Tongmai Tang combined with western medical conventional therapy may reduce restenosis after coronary artery stenting
and obviously relieve clinical symptoms of postoperative patients. Its mechanism may be related to improve blood lipid and reduce plasma levels of ox-LDL and hs-CRP.
0
浏览量
234
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010102007558号